Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I wouldn’t be surprised if stonechecker is taken off the books nobody’s wants it old hat technology
Agreed, that is my position.
Drax , I dont think that many LTH's still believe that Stonechecker is going to generate a large pay day and are holding because they hope IB will be successful medium term.
The sale of Stonechecker will increase company value but is a small part of the business - the IB software is where the huge potential is here & would expect to hear an update on broadening its use soon.
The news should be - Telemedicine launch/partnership within the next couple of weeks followed by Sharetalk interview/s which should ramp up the interest in the company, SC sale could be anytime, Gadolinium free project still on schedule, IB stroke package, 510K FDA clearance on Liver Nodularity & multiple usage of IB software again could be anytime & would expect an mention in the interviews .
2 largish sells, and smaller buys but nobody interested in buying stock, up to management to change that and hopefully soon!
True.
Many seem to feel that Stonechecker will be the salvation of this share but I doubt it will be sold. If it is sold I would bet a lot of money it does not fetch £500,000.
Time will tell, as always m8.
Dream on my friend.
Sp is news driven and there is no news, has not been any news and there is no sign of news!
No conspiracy, simply lack of demand for a share deep in the doldrums
Mm's trying to buy cheap before it takes off. I had the same situation on Friday on MNO. Stonechecker sale finalised?
Can be interesting, I've just topped up.
bothers me that Horizon2020 funds could be heading to new competition in AI imaging and they splash the cash like its someone else's - which it is of course.
A bit of patience and it will be in double digits again
Sell this dead duck and get into the junior gold mining space you lot didn’t listen to me when I told folk to sell when in double digits listen to me now buy a Canadian gold stock called East Asia Minerals, ticker EAS listed on the TSX they are on the brink of getting there production licence which is the equivalent to an Fda approval I can’t keep giving this tremendous advice if folk don’t listen
Hopefully we will find out shortly and recover some of the costs involved in getting the FDA approvals. As it sits outside the scope of the main business I agree with their strategy of selling it. As you say we shall see where they get too...
My doubts are confined to the Stonechecker sale.
The fact that we have been unable to do anything with it before or after FDA approval
suggest an unwanted and unsaleable white elephant.
We shall see!!
if we were sat...
@Drax, if we we not sat at an inflated market cap I could see your position, but really if you believe that AI has the capacity to transform the medical imaging industry then this really is a good entrance point. I originally bought in a just below 2p and sold my original investment at 10p to leave the profit in here. I bought a significant chunk. IB has a really interesting suite of SW in an emerging area of the tech industry. There aren't many UK listed businesses in this space which makes it even more interesting... of course there are always risks but this seems to have most basis covered...
I remain a sceptic.
Trevor Brown CEO of IQ-AI Limited commented "In addition to this excellent news, I am please to report that the process of finding a buyer for Stonechecker software has now recommenced with discussions under way with two parties. There is no certainty of a satisfactory conclusion of these discussions and we will update shareholders as appropriate. The Board is also exploring a new initiative in telemedicine and looking at the wider application of IB technology and products."